Restoration of miR-200 expression suppresses proliferation and mobility of pancreatic cancer cell
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025
DOI: 10.1007/s00210-024-03717-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Guiming Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, NHC Key Laboratory of Hormones and Development and Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial …. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, MicroRNAs, Cell Movement. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Mobilisation
Abstract (Originalsprache)
A number of various human malignancies have been associated with abnormal microRNAs (miRNA) expression. There are evidence that miR-200 operates as both tumor suppressor and an onco-miR in a variety of tumors. In this study, we evaluated the effects of miR-200 on the proliferation and migration of pancreatic cancer cells, as well as the underlying molecular pathways. Clinical tissue samples were used to investigate the expression of miR-200 in pancreatic cancer and normal tissues, and the gene expression omnibus (GEO) database provided bioinformatics confirmation. Using the pCMV vector, miR-200 was transfected into PANC-1 pancreatic cancer cells. After transfection, expression of cancer-related genes (at the mRNA and protein levels) was evaluated. The miR-200-transfected pancreatic cancer cells' survival, invasion, migration, and apoptosis were also investigated. According to the bioinformatics analysis, decreased miR-200 expression was associated with a worse prognosis in pancreatic cancer patients. Moreover, low levels of miR-200 in pancreatic cancer tissues were approved. After transfection, pancreatic cancer cells exhibit a sustained increase in expression of miR-200, which inhibits cell viability, invasion, and migration. Additional investigations revealed that increasing expression of miR-200 increases the proportion of pancreatic cancer cells that endure apoptosis. Changes in the mRNA and protein expression of apoptosis- and metastasis-related genes may account for these findings. Our results indicate that miR-200 functions as a tumor suppressor in pancreatic cancer cells and that upregulating miR-200 levels may be a useful therapeutic strategy for pancreatic cancer patients to halt the progression of the illness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, NHC Key Laboratory of Hormones and Development and Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical Univers…
- Department of General Surgery, Tianjin First Center Hospital, Tianji, 300384, China. wanggm2323@126.com.
Zitieren
APA
Wang, G., Pan, L., & Guo, R. (2025). Restoration of miR-200 expression suppresses proliferation and mobility of pancreatic cancer cell. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03717-0
Vancouver
Wang G, Pan L, Guo R. Restoration of miR-200 expression suppresses proliferation and mobility of pancreatic cancer cell. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-024-03717-0
BibTeX
@article{Wang2025,
author = {Wang, Guiming and Pan, Lifeng and Guo, Rende},
title = {Restoration of miR-200 expression suppresses proliferation and mobility of pancreatic cancer cell},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
doi = {10.1007/s00210-024-03717-0}
}
EUVIMED